 | • レポートコード：MRC2-11QY12379 • 出版社/出版日：QYResearch / 2020年11月25日 ※2024年版があります。お問い合わせください。 • レポート形態：英文、PDF、94ページ • 納品方法：Eメール（納期：2~3日） • 産業分類：ヘルスケア |
| Single User | ￥585,000 (USD3,900) | ▷ お問い合わせ |
| Multi User | ￥877,500 (USD5,850) | ▷ お問い合わせ |
| Enterprise License | ￥1,170,000 (USD7,800) | ▷ お問い合わせ |
• お支払方法：銀行振込（納品後、ご請求書送付）
レポート概要
| 当調査資料はインフルエンザ診断のグローバル市場について調査・分析したレポートです。種類別（RIDT、RT-PCR、細胞培養、その他）市場規模、用途別（病院、POCT、その他）市場規模、地域別（北米、米国、カナダ、ヨーロッパ、ドイツ、フランス、イギリス、イタリア、ロシア、アジア、日本、中国、韓国、インド、オーストラリア、台湾、中南米、メキシコ、ブラジル、アルゼンチン、中東・アフリカ、トルコ、サウジアラビア、UAE等）市場規模データ、主な企業情報と企業別市場シェア等が収録されています。 ・調査範囲 ・エグゼクティブサマリー ・企業別インフルエンザ診断の競争状況、市場シェア ・世界のインフルエンザ診断市場：種類別市場規模 2015年-2020年（RIDT、RT-PCR、細胞培養、その他） ・世界のインフルエンザ診断市場：種類別市場規模予測 2021年-2026年（RIDT、RT-PCR、細胞培養、その他） ・世界のインフルエンザ診断市場：用途別市場規模 2015年-2020年（病院、POCT、その他） ・世界のインフルエンザ診断市場：用途別市場規模予測 2021年-2026年（病院、POCT、その他） ・北米のインフルエンザ診断市場分析：米国、カナダ ・ヨーロッパのインフルエンザ診断市場分析：ドイツ、フランス、イギリス、イタリア、ロシア等 ・アジアのインフルエンザ診断市場分析：日本、中国、韓国、インド、オーストラリア、台湾等 ・中南米のインフルエンザ診断市場分析：メキシコ、ブラジル、アルゼンチン等 ・中東・アフリカのインフルエンザ診断市場分析：トルコ、サウジアラビア、UAE等 ・企業情報（企業概要、製品概要、販売量、企業動向） - 掲載企業（変更可能性あり）：BD、Abbott (Include Alere)、Roche、SIEMENS、Analytik Jena、Quidel、Thermo Fisher、Meridian Bioscience、BioMerieux、Sekisui Diagnostics、Response Biomedical、SA Scientific ・地域別市場規模予測（2021年-2026年）：北米市場、ヨーロッパ市場、アジア市場、中南米市場、中東・アフリカ市場 ・市場機会、課題、リスク、環境分析 ・バリューチェーン、販売チャネル分析 ・調査の結論 |
Influenza is an infectious disease and affects the upper respiratory tract in humans. The disease is common in children and elderly population (aged 65 years and above). The disease has a huge impact on Public Company health. Influenza A virus poses a greater risk as compared to the influenza B virus. The B virus is responsible for 20% to 25% of infections globally. Proper collection, storage and transport of respiratory specimens are the essential first step for laboratory detection of influenza virus infections. Laboratory confirmation of influenza virus from throat, nasal and nasopharyngeal secretions or tracheal aspirate or washings is commonly performed using direct antigen detection, virus isolation, or detection of influenza-specific RNA by reverse transcriptase-polymerase chain reaction (RT-PCR).
The major producers in this industry are BD, Abbott (Include Alere) and Roche, whose combined revenue ratio in 2019 is 50.61%.
Market Analysis and Insights: Global Influenza Diagnostics Market
The global Influenza Diagnostics market size is projected to reach US$ 3174.9 million by 2026, from US$ 2195.6 million in 2020, at a CAGR of 6.3% during 2021-2026.
With industry-standard accuracy in analysis and high data integrity, the report makes a brilliant attempt to unveil key opportunities available in the global Influenza Diagnostics market to help players in achieving a strong market position. Buyers of the report can access verified and reliable market forecasts, including those for the overall size of the global Influenza Diagnostics market in terms of revenue.
On the whole, the report proves to be an effective tool that players can use to gain a competitive edge over their competitors and ensure lasting success in the global Influenza Diagnostics market. All of the findings, data, and information provided in the report are validated and revalidated with the help of trustworthy sources. The analysts who have authored the report took a unique and industry-best research and analysis approach for an in-depth study of the global Influenza Diagnostics market.
Global Influenza Diagnostics Scope and Market Size
Influenza Diagnostics market is segmented by Type, and by Application. Players, stakeholders, and other participants in the global Influenza Diagnostics market will be able to gain the upper hand as they use the report as a powerful resource. The segmental analysis focuses on revenue and forecast by Type and by Application in terms of revenue and forecast for the period 2015-2026.
Market segment by Type, the product can be split into
RIDT
RT-PCR
Cell Culture
Others
Market segment by Application, split into
Hospitals
POCT
Others
Based on regional and country-level analysis, the Influenza Diagnostics market has been segmented as follows:
North America
United States
Canada
Europe
Germany
France
U.K.
Italy
Russia
Nordic
Rest of Europe
Asia-Pacific
China
Japan
South Korea
Southeast Asia
India
Australia
Rest of Asia-Pacific
Latin America
Mexico
Brazil
Middle East & Africa
Turkey
Saudi Arabia
UAE
Rest of Middle East & Africa
In the competitive analysis section of the report, leading as well as prominent players of the global Influenza Diagnostics market are broadly studied on the basis of key factors. The report offers comprehensive analysis and accurate statistics on revenue by the player for the period 2015-2020. It also offers detailed analysis supported by reliable statistics on price and revenue (global level) by player for the period 2015-2020.
The key players covered in this study
BD
Abbott (Include Alere)
Roche
SIEMENS
Analytik Jena
Quidel
Thermo Fisher
Meridian Bioscience
BioMerieux
Sekisui Diagnostics
1 Report Overview
1.1 Study Scope
1.2 Market Analysis by Type
1.2.1 Global Influenza Diagnostics Market Size Growth Rate by Type: 2020 VS 2026
1.2.2 RIDT
1.2.3 RT-PCR
1.2.4 Cell Culture
1.2.5 Others
1.3 Market by Application
1.3.1 Global Influenza Diagnostics Market Share by Application: 2020 VS 2026
1.3.2 Hospitals
1.3.3 POCT
1.3.4 Others
1.4 Study Objectives
1.5 Years Considered
2 Global Growth Trends
2.1 Global Influenza Diagnostics Market Perspective (2015-2026)
2.2 Global Influenza Diagnostics Growth Trends by Regions
2.2.1 Influenza Diagnostics Market Size by Regions: 2015 VS 2020 VS 2026
2.2.2 Influenza Diagnostics Historic Market Share by Regions (2015-2020)
2.2.3 Influenza Diagnostics Forecasted Market Size by Regions (2021-2026)
2.3 Industry Trends and Growth Strategy
2.3.1 Market Trends
2.3.2 Market Drivers
2.3.3 Market Challenges
2.3.4 Market Restraints
3 Competition Landscape by Key Players
3.1 Global Top Influenza Diagnostics Players by Market Size
3.1.1 Global Top Influenza Diagnostics Players by Revenue (2015-2020)
3.1.2 Global Influenza Diagnostics Revenue Market Share by Players (2015-2020)
3.2 Global Influenza Diagnostics Market Share by Company Type (Tier 1, Tier 2 and Tier 3)
3.3 Players Covered: Ranking by Influenza Diagnostics Revenue
3.4 Global Influenza Diagnostics Market Concentration Ratio
3.4.1 Global Influenza Diagnostics Market Concentration Ratio (CR5 and HHI)
3.4.2 Global Top 10 and Top 5 Companies by Influenza Diagnostics Revenue in 2019
3.5 Key Players Influenza Diagnostics Area Served
3.6 Key Players Influenza Diagnostics Product Solution and Service
3.7 Date of Enter into Influenza Diagnostics Market
3.8 Mergers & Acquisitions, Expansion Plans
4 Influenza Diagnostics Breakdown Data by Type (2015-2026)
4.1 Global Influenza Diagnostics Historic Market Size by Type (2015-2020)
4.2 Global Influenza Diagnostics Forecasted Market Size by Type (2021-2026)
5 Influenza Diagnostics Breakdown Data by Application (2015-2026)
5.1 Global Influenza Diagnostics Historic Market Size by Application (2015-2020)
5.2 Global Influenza Diagnostics Forecasted Market Size by Application (2021-2026)
6 North America
6.1 North America Influenza Diagnostics Market Size (2015-2026)
6.2 North America Influenza Diagnostics Market Size by Type (2015-2020)
6.3 North America Influenza Diagnostics Market Size by Application (2015-2020)
6.4 North America Influenza Diagnostics Market Size by Country (2015-2020)
6.4.1 United States
6.4.2 Canada
7 Europe
7.1 Europe Influenza Diagnostics Market Size (2015-2026)
7.2 Europe Influenza Diagnostics Market Size by Type (2015-2020)
7.3 Europe Influenza Diagnostics Market Size by Application (2015-2020)
7.4 Europe Influenza Diagnostics Market Size by Country (2015-2020)
7.4.1 Germany
7.4.2 France
7.4.3 U.K.
7.4.4 Italy
7.4.5 Russia
7.4.6 Nordic
7.4.7 Rest of Europe
(2015-2020)
(2015-2020)
.4 Influenza Diagnostics Market Size by Region (2015-2020)
8.4.1 China
8.4.2 Japan
8.4.3 South Korea
8.4.4 Southeast Asia
8.4.5 India
8.4.6 Australia
8.4.7 Rest of Asia-Pacific
(2015-2020)
(2015-2020)
.4 Influenza Diagnostics Market Size by Country (2015-2020)
9.4.1 Mexico
9.4.2 Brazil
.4 Influenza Diagnostics Market Size by Country (2015-2020)
10.4.1 Turkey
10.4.2 Saudi Arabia
10.4.3 UAE
10.4.4 Rest of Middle East & Africa
8Key Players Profiles
8.1 BD
8.1.1 BD Company Details
8.1.2 BD Business Overview
8.1.3 BD Influenza Diagnostics Introduction
8.1.4 BD Revenue in Influenza Diagnostics Business (2015-2020))
8.1.5 BD Recent Development
8.2 Abbott (Include Alere)
8.2.1 Abbott (Include Alere) Company Details
8.2.2 Abbott (Include Alere) Business Overview
8.2.3 Abbott (Include Alere) Influenza Diagnostics Introduction
8.2.4 Abbott (Include Alere) Revenue in Influenza Diagnostics Business (2015-2020)
8.2.5 Abbott (Include Alere) Recent Development
8.3 Roche
8.3.1 Roche Company Details
8.3.2 Roche Business Overview
8.3.3 Roche Influenza Diagnostics Introduction
8.3.4 Roche Revenue in Influenza Diagnostics Business (2015-2020)
8.3.5 Roche Recent Development
8.4 SIEMENS
8.4.1 SIEMENS Company Details
8.4.2 SIEMENS Business Overview
8.4.3 SIEMENS Influenza Diagnostics Introduction
8.4.4 SIEMENS Revenue in Influenza Diagnostics Business (2015-2020)
8.4.5 SIEMENS Recent Development
8.5 Analytik Jena
8.5.1 Analytik Jena Company Details
8.5.2 Analytik Jena Business Overview
8.5.3 Analytik Jena Influenza Diagnostics Introduction
8.5.4 Analytik Jena Revenue in Influenza Diagnostics Business (2015-2020)
8.5.5 Analytik Jena Recent Development
8.6 Quidel
8.6.1 Quidel Company Details
8.6.2 Quidel Business Overview
8.6.3 Quidel Influenza Diagnostics Introduction
8.6.4 Quidel Revenue in Influenza Diagnostics Business (2015-2020)
8.6.5 Quidel Recent Development
8.7 Thermo Fisher
8.7.1 Thermo Fisher Company Details
8.7.2 Thermo Fisher Business Overview
8.7.3 Thermo Fisher Influenza Diagnostics Introduction
8.7.4 Thermo Fisher Revenue in Influenza Diagnostics Business (2015-2020)
8.7.5 Thermo Fisher Recent Development
8.8 Meridian Bioscience
8.8.1 Meridian Bioscience Company Details
8.8.2 Meridian Bioscience Business Overview
8.8.3 Meridian Bioscience Influenza Diagnostics Introduction
8.8.4 Meridian Bioscience Revenue in Influenza Diagnostics Business (2015-2020)
8.8.5 Meridian Bioscience Recent Development
8.9 BioMerieux
8.9.1 BioMerieux Company Details
8.9.2 BioMerieux Business Overview
8.9.3 BioMerieux Influenza Diagnostics Introduction
8.9.4 BioMerieux Revenue in Influenza Diagnostics Business (2015-2020)
8.9.5 BioMerieux Recent Development
8.10 Sekisui Diagnostics
8.10.1 Sekisui Diagnostics Company Details
8.10.2 Sekisui Diagnostics Business Overview
8.10.3 Sekisui Diagnostics Influenza Diagnostics Introduction
8.10.4 Sekisui Diagnostics Revenue in Influenza Diagnostics Business (2015-2020)
8.10.5 Sekisui Diagnostics Recent Development
8.11 Response Biomedical
10.11.1 Response Biomedical Company Details
10.11.2 Response Biomedical Business Overview
10.11.3 Response Biomedical Influenza Diagnostics Introduction
10.11.4 Response Biomedical Revenue in Influenza Diagnostics Business (2015-2020)
10.11.5 Response Biomedical Recent Development
8.12 SA Scientific
10.12.1 SA Scientific Company Details
10.12.2 SA Scientific Business Overview
10.12.3 SA Scientific Influenza Diagnostics Introduction
10.12.4 SA Scientific Revenue in Influenza Diagnostics Business (2015-2020)
10.12.5 SA Scientific Recent Development
9Analyst’s Viewpoints/Conclusions
10Appendix
10.1 Research Methodology
10.1.1 Methodology/Research Approach
10.1.2 Data Source
10.2 Disclaimer
10.3 Author Details
Table 1. Global Influenza Diagnostics Market Size Growth Rate by Type (US$ Million): 2020 VS 2026
Table 3. Key Players of RIDT
Table 4. Key Players of RT-PCR
Table 5. Key Players of Cell Culture
Table 6. Key Players of Others
Table 7. Global Influenza Diagnostics Market Size Growth by Application (US$ Million): 2020 VS 2026
Table 8. Global Influenza Diagnostics Market Size by Regions (US$ Million): 2020 VS 2026
Table 9. Global Influenza Diagnostics Market Size by Regions (2015-2020) (US$ Million)
Table 10. Global Influenza Diagnostics Market Share by Regions (2015-2020)
Table 11. Global Influenza Diagnostics Forecasted Market Size by Regions (2021-2026) (US$ Million)
Table 12. Global Influenza Diagnostics Market Share by Regions (2021-2026)
Table 13. Influenza Diagnostics Market Market Trends
Table 14. Influenza Diagnostics Market Drivers
Table 15. Influenza Diagnostics Market Challenges
Table 16. Influenza Diagnostics Market Restraints
Table 17. Global Influenza Diagnostics Revenue by Players (2015-2020) (US$ Million)
Table 18. Global Influenza Diagnostics Market Share by Players (2015-2020)
Table 19. Global Top Influenza Diagnostics Players by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in Influenza Diagnostics as of 2019)
Table 20. Global Influenza Diagnostics by Players Market Concentration Ratio (CR5 and HHI)
Table 21. Key Players Headquarters and Area Served
Table 22. Key Players Influenza Diagnostics Product Solution and Service
Table 23. Mergers & Acquisitions, Expansion Plans
Table 24. Global Influenza Diagnostics Market Size by Type (2015-2020) (US$ Million)
Table 25. Global Influenza Diagnostics Market Size Share by Type (2015-2020)
Table 26. Global Influenza Diagnostics Revenue Market Share by Type (2021-2026)
Table 27. Global Influenza Diagnostics Market Size Share by Application (2015-2020)
Table 28. Global Influenza Diagnostics Market Size by Application (2015-2020) (US$ Million)
Table 29. Global Influenza Diagnostics Market Size Share by Application (2021-2026)
Table 30. North America Influenza Diagnostics Market Size by Type (2015-2020) (US$ Million)
Table 31. North America Influenza Diagnostics Market Share by Type (2015-2020)
Table 32. North America Influenza Diagnostics Market Size by Application (2015-2020) (US$ Million)
Table 33. North America Influenza Diagnostics Market Share by Application (2015-2020)
Table 34. North America Influenza Diagnostics Market Size by Country (US$ Million) (2015-2020)
Table 35. North America Influenza Diagnostics Market Share by Country (2015-2020)
Table 36. Europe Influenza Diagnostics Market Size by Type (2015-2020) (US$ Million)
Table 37. Europe Influenza Diagnostics Market Share by Type (2015-2020)
Table 38. Europe Influenza Diagnostics Market Size by Application (2015-2020) (US$ Million)
Table 39. Europe Influenza Diagnostics Market Share by Application (2015-2020)
Table 40. Europe Influenza Diagnostics Market Size by Country (US$ Million) (2015-2020)
Table 41. Europe Influenza Diagnostics Market Share by Country (2015-2020)
Table 42. Influenza Diagnostics Market Size by Region (US$ Million) (2015-2020)
Table 43. Influenza Diagnostics Market Share by Region (2015-2020)
Table 44. Influenza Diagnostics Market Size by Country (US$ Million) (2015-2020)
Table 45. Influenza Diagnostics Market Share by Country (2015-2020)
Table 46. Influenza Diagnostics Market Size by Country (US$ Million) (2015-2020)
Table 47. Influenza Diagnostics Market Share by Country (2015-2020)
Table 48. BD Company Details
Table 49. BD Business Overview
Table 50. BD Product
Table 51. BD Revenue in Influenza Diagnostics Business (2015-2020) (US$ Million)
Table 52. BD Recent Development
Table 53. Abbott (Include Alere) Company Details
Table 54. Abbott (Include Alere) Business Overview
Table 55. Abbott (Include Alere) Product
Table 56. Abbott (Include Alere) Revenue in Influenza Diagnostics Business (2015-2020) (US$ Million)
Table 57. Abbott (Include Alere) Recent Development
Table 58. Roche Company Details
Table 59. Roche Business Overview
Table 60. Roche Product
Table 61. Roche Revenue in Influenza Diagnostics Business (2015-2020) (US$ Million)
Table 62. Roche Recent Development
Table 63. SIEMENS Company Details
Table 64. SIEMENS Business Overview
Table 65. SIEMENS Product
Table 66. SIEMENS Revenue in Influenza Diagnostics Business (2015-2020) (US$ Million)
Table 67. SIEMENS Recent Development
Table 68. Analytik Jena Company Details
Table 69. Analytik Jena Business Overview
Table 70. Analytik Jena Product
Table 71. Analytik Jena Revenue in Influenza Diagnostics Business (2015-2020) (US$ Million)
Table 72. Analytik Jena Recent Development
Table 73. Quidel Company Details
Table 74. Quidel Business Overview
Table 75. Quidel Product
Table 76. Quidel Revenue in Influenza Diagnostics Business (2015-2020) (US$ Million)
Table 77. Quidel Recent Development
Table 78. Thermo Fisher Company Details
Table 79. Thermo Fisher Business Overview
Table 80. Thermo Fisher Product
Table 81. Thermo Fisher Revenue in Influenza Diagnostics Business (2015-2020) (US$ Million)
Table 82. Thermo Fisher Recent Development
Table 83. Meridian Bioscience Business Overview
Table 84. Meridian Bioscience Product
Table 85. Meridian Bioscience Company Details
Table 86. Meridian Bioscience Revenue in Influenza Diagnostics Business (2015-2020) (US$ Million)
Table 87. Meridian Bioscience Recent Development
Table 88. BioMerieux Company Details
Table 89. BioMerieux Business Overview
Table 90. BioMerieux Product
Table 91. BioMerieux Revenue in Influenza Diagnostics Business (2015-2020) (US$ Million)
Table 92. BioMerieux Recent Development
Table 93. Sekisui Diagnostics Company Details
Table 94. Sekisui Diagnostics Business Overview
Table 95. Sekisui Diagnostics Product
Table 96. Sekisui Diagnostics Revenue in Influenza Diagnostics Business (2015-2020) (US$ Million)
Table 97. Sekisui Diagnostics Recent Development
Table 98. Response Biomedical Company Details
Table 99. Response Biomedical Business Overview
Table 100. Response Biomedical Product
Table 101. Response Biomedical Revenue in Influenza Diagnostics Business (2015-2020) (US$ Million)
Table 102. Response Biomedical Recent Development
Table 103. SA Scientific Company Details
Table 104. SA Scientific Business Overview
Table 105. SA Scientific Product
Table 106. SA Scientific Revenue in Influenza Diagnostics Business (2015-2020) (US$ Million)
Table 107. SA Scientific Recent Development
Table 108. Research Programs/Design for This Report
Table 109. Key Data Information from Secondary Sources
Table 110. Key Data Information from Primary Sources
List of Figures
Figure 1. Global Influenza Diagnostics Market Share by Type: 2020 VS 2026
Figure 2. RIDT Features
Figure 3. RT-PCR Features
Figure 4. Cell Culture Features
Figure 5. Others Features
Figure 6. Global Influenza Diagnostics Market Share by Application: 2020 VS 2026
Figure 7. Hospitals Case Studies
Figure 8. POCT Case Studies
Figure 9. Others Case Studies
Figure 10. Influenza Diagnostics Report Years Considered
Figure 11. Global Influenza Diagnostics Market Size (US$ Million), YoY Growth 2015-2026
Figure 12. Global Influenza Diagnostics Market Share by Regions: 2020 VS 2026
Figure 13. Global Influenza Diagnostics Market Share by Regions (2021-2026)
Figure 14. Global Influenza Diagnostics Market Share by Players in 2019
Figure 15. Global Top Influenza Diagnostics Players by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in Influenza Diagnostics as of 2019
Figure 16. The Top 10 and 5 Players Market Share by Influenza Diagnostics Revenue in 2019
Figure 17. North America Influenza Diagnostics Market Size YoY Growth (2015-2026) & (US$ Million)
Figure 18. United States Influenza Diagnostics Market Size YoY Growth (2015-2026) & (US$ Million)
Figure 19. Canada Influenza Diagnostics Market Size YoY Growth (2015-2026) & (US$ Million)
Figure 20. Europe Influenza Diagnostics Market Size YoY Growth (2015-2026) & (US$ Million)
Figure 21. Germany Influenza Diagnostics Market Size YoY Growth (2015-2026) & (US$ Million)
Figure 22. France Influenza Diagnostics Market Size YoY Growth (2015-2026) & (US$ Million)
Figure 23. U.K. Influenza Diagnostics Market Size YoY Growth (2015-2026) & (US$ Million)
Figure 24. Italy Influenza Diagnostics Market Size YoY Growth (2015-2026) & (US$ Million)
Figure 25. Russia Influenza Diagnostics Market Size YoY Growth (2015-2026) & (US$ Million)
Figure 26. Nordic Influenza Diagnostics Market Size YoY Growth (2015-2026) & (US$ Million)
Figure 27. Rest of Europe Influenza Diagnostics Market Size YoY Growth (2015-2026) & (US$ Million)
Figure 28. Asia-Pacific Influenza Diagnostics Market Size YoY Growth (2015-2026) & (US$ Million)
Figure 29. China Influenza Diagnostics Market Size YoY Growth (2015-2026) & (US$ Million)
Figure 30. Japan Influenza Diagnostics Market Size YoY Growth (2015-2026) & (US$ Million)
Figure 31. South Korea Influenza Diagnostics Market Size YoY Growth (2015-2026) & (US$ Million)
Figure 32. Southeast Asia Influenza Diagnostics Market Size YoY Growth (2015-2026) & (US$ Million)
Figure 33. India Influenza Diagnostics Market Size YoY Growth (2015-2026) & (US$ Million)
Figure 34. Australia Influenza Diagnostics Market Size YoY Growth (2015-2026) & (US$ Million)
Figure 35. Rest of Asia-Pacific Influenza Diagnostics Market Size YoY Growth (2015-2026) & (US$ Million)
Figure 36. Latin America Influenza Diagnostics Market Size YoY Growth (2015-2026) & (US$ Million)
Figure 37. Mexico Influenza Diagnostics Market Size YoY Growth (2015-2026) & (US$ Million)
Figure 38. Brazil Influenza Diagnostics Market Size YoY Growth (2015-2026) & (US$ Million)
Figure 39. Middle East & Africa Influenza Diagnostics Market Size YoY Growth (2015-2026) & (US$ Million)
Figure 40. Turkey Influenza Diagnostics Market Size YoY Growth (2015-2026) & (US$ Million)
Figure 41. Saudi Arabia Influenza Diagnostics Market Size YoY Growth (2015-2026) & (US$ Million)
Figure 42. UAE Influenza Diagnostics Market Size YoY Growth (2015-2026) & (US$ Million)
Figure 43. Rest of Middle East & Africa Influenza Diagnostics Market Size YoY Growth (2015-2026) & (US$ Million)
Figure 44. BD Revenue Growth Rate in Influenza Diagnostics Business (2015-2020)
Figure 45. Abbott (Include Alere) Revenue Growth Rate in Influenza Diagnostics Business (2015-2020)
Figure 46. Roche Revenue Growth Rate in Influenza Diagnostics Business (2015-2020)
Figure 47. SIEMENS Revenue Growth Rate in Influenza Diagnostics Business (2015-2020)
Figure 48. Analytik Jena Revenue Growth Rate in Influenza Diagnostics Business (2015-2020)
Figure 49. Quidel Revenue Growth Rate in Influenza Diagnostics Business (2015-2020)
Figure 50. Thermo Fisher Revenue Growth Rate in Influenza Diagnostics Business (2015-2020)
Figure 51. Meridian Bioscience Revenue Growth Rate in Influenza Diagnostics Business (2015-2020)
Figure 52. BioMerieux Revenue Growth Rate in Influenza Diagnostics Business (2015-2020)
Figure 53. Sekisui Diagnostics Revenue Growth Rate in Influenza Diagnostics Business (2015-2020)
Figure 54. Response Biomedical Revenue Growth Rate in Influenza Diagnostics Business (2015-2020)
Figure 55. SA Scientific Revenue Growth Rate in Influenza Diagnostics Business (2015-2020)
Figure 56. Bottom-up and Top-down Approaches for This Report
Figure 57. Data Triangulation
Figure 58. Key Executives Interviewed
インフルエンザワクチン接種の世界市場（～2026年） Influenza (flu) is a contagious respiratory disease caused by influenza viruses that infect the respiratory tract (nose, throat, and lungs) in humans. The symptoms and complications of flu are more severe than common cold. The symptoms associated with influenza may include fever, headache, malaise, …- 犬用インフルエンザワクチンの世界市場（～2026年） Market Analysis and Insights: Global Canine Influenza Vaccine Market The global Canine Influenza Vaccine market size is projected to reach US$ XX million by 2026, from US$ XX million in 2020, at a CAGR of XX%% during 2021-2026. Global Canine Influenza Vaccine Scope and Market Size Canine Influenza V…
- 馬インフルエンザワクチンの世界市場（～2026年） Market Analysis and Insights: Global Equine Influenza Vaccine Market The global Equine Influenza Vaccine market size is projected to reach US$ XX million by 2026, from US$ XX million in 2020, at a CAGR of XX%% during 2021-2026. Global Equine Influenza Vaccine Scope and Market Size Equine Influenza V…
- インフルエンザ治療薬の世界市場（～2026年） Influenza medication includes antiviral drugs prescribed for the treatment of influenza. Influenza, also known as flu, is a respiratory disease caused by an influenza virus. It is a viral infectious disease that includes three major types: type A, type B, and type C. The common symptoms of the disor…
- インフルエンザ薬の世界市場（～2026年） Market Analysis and Insights: Global Influenza Drugs Market The global Influenza Drugs market size is projected to reach US$ XX million by 2026, from US$ XX million in 2020, at a CAGR of XX%% during 2021-2026. Global Influenza Drugs Scope and Market Size Influenza Drugs market is segmented by Type, …